Efficacy and safety of Mepolizumab in a real world severe asthma cohort.
v. Mitchell (Birmingham, United Kingdom), K. Howles (Birmingham, United Kingdom), L. White (Birmingham, United Kingdom), A. Pillai (Birmingham, United Kingdom), A. Mansur (Birmingham, United Kingdom)
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Disease area: Airway diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
v. Mitchell (Birmingham, United Kingdom), K. Howles (Birmingham, United Kingdom), L. White (Birmingham, United Kingdom), A. Pillai (Birmingham, United Kingdom), A. Mansur (Birmingham, United Kingdom). Efficacy and safety of Mepolizumab in a real world severe asthma cohort.. 2523
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: